[ 5 ] Abramson SB. Nitric oxide in inflammation and pain associated with osteoarthritis[J]. Arthritis Res Ther, 2008, l0(Suppl 2): 2.
[6]
[ 6 ] Mix KS, Mengshol JA, Benbow U, et al. A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines[J]. Arthritis Rheum, 2001, 44(5): 1096-1104.
[7]
[ 7 ] Daheshia M, Yao JQ. The interleukin 1beta pathway in the pathogenesis of osteoarthritis[J]. Rheum, 2008, 35(12): 2306-2312.
[8]
[ 8 ] Wang X, Li F, Fan C, et al. Effects and relationship of ERK1 and ERK2 in interleukin-1β-induced alteration in MMP3, MMP13, type Ⅱcollagen and aggrecan expression in human chondrocytes[J]. Int J Mol Med, 2011, 27(4): 583-589.
[9]
[ 9 ] Im HJ, Pacione C, Chubinskaya S, et al. Inhibitory effects of fibronectin fragment and interleukin-1β-stimulated matrix metal oproteinase-13 expression in human chondrocytes[J]. J Biol Chem, 2003, 278(28): 25386-25394.
[10]
Ghivizzani SC, Kang R, Georgescu HI, et al. Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis[J]. J Immunol, 1997, 159(7): 3604-3612.
[11]
Tak PP, Gerlag DM, Aupperle KR, et al. Inhibitor of nuclear factor kappa B kinase beta is a key regulator of synovial inflammation[J]. Arthritis Rheum, 2001, 44(8): 1897-1907.
Davies CM, Guilak F, Weinberg JB, et al. Reactive Nitrogen and Oxygen species interleukin-1β-mediated DNA damage associated with osteoarthritis[J]. Osteoarthritis Cartilage, 2008, 16(5): 624-630.
[16]
Hashimoto S, Setareh M, Ochs RL, et al. Fas/Fas ligand expression and induction of apoptosis in chondrocytes[J]. Arthritis Rheum, 1997, 40(10): 1749-1755.
[17]
Zheng X, Xia C, Chen Z, et al. Requirement of the phosphatidylinositol 3-kinase/Akt signaling pathway for the effect of nicotine on interleukin-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis[J]. Biochem Biophys Res Commun, 2012, 423(3): 606-612.
Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin[J]. Science, 2005, 307(5708): 426-430.
[20]
Sethi JK, Vidal-Puig A. Visfatin: the missing Link between intra-abdominal obesity and diabetes[J]. Trends Mol Med, 2005, 11(8): 344-347.
[21]
de Boer TN, van Spil WE, Huisman AM, et al. Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage[J]. Osteoarthritis Cartilage, 2012, 20(8): 846-853.
[22]
Busso N, Karababa M, Nobile M, et al. Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD[J]. PLoS One, 2008, 3(5): e2267.
[23]
Toda Y, Toda T, Takemura S, et al. Change in body fat,but not body weight or metabolic correlates of obesity,is related to symptomatic relief of obese patients with knee osteoarthritis after a weight control program[J]. Rheum, 1998, 25(11): 2181-2186.
[24]
Hedbom E, H？uselmann HJ. Motecular aspects of pathogenesis in osteoarthrithe role of inflammation[J]. Cell Mot Life Sci, 2002, 59(1): 45-53.
[25]
Tsou HK, Chen HT, Chang CH, et al. Apoptosis signal-regulating kinase 1 is mediated in TNF-α-induced CCL2 expression in human synovial fibroblasts[J]. J Cell Biochem, 2012, 113(11): 3509-3519.
[26]
Kostopoulou F, Gkretsi V, Malizos KN, et al. Central role of SREBP-2 in the pathogenesis of osteoarthritis[J]. PLoS One, 2012, 7(5): e35753.
Chen DY, Lan JL, Lin FJ. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still’s disease[J]. Ann Rheum Dis, 2004, 63(10): 1300-1306.
[29]
Meini S, Cucchi P, Tinti L, et al. Fasitibant prevents the bradykinin and interleukin 1β synergism on prostaglandin E2 release and cyclooxygenase 2 expression in human fibroblast-like synoviocytes[J]. Naunyn Schmiedebergs Arch Pharmacol, 2012, 385(8): 777-786.
[30]
Lee YA, Choi HM, Lee SH, et al. Synergy between adiponectin and interleukin-1β on the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in fibroblast-like synoviocytes[J]. Exp Mol Med, 2012, 44(7): 440-447.
[31]
Kawaguchi H. Regulation of osteoarthritis development by Wnt-beta-catenin signaling through the endochondral ossification process[J]. J Bone Miner Res, 2009, 24(1): 8-11.
[32]
Dell’accio F, De Bari C, Eltawil NM, et al. Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis[J]. Arthritis Rheum, 2008, 58(5): 1410-1421.
[33]
Zhu M, Tang D, Wu Q, et al. Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice[J]. J Bone Miner Res, 2009, 24(1): 12-21.
[34]
Day TF, Guo X, Garrett-Beal L, et al. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis[J]. Dev Cell, 2005, 8(5): 739-750.
[35]
Tamamura Y, Otani T, Kanatani N, et al. Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification[J]. J Biol Chem, 2005, 280(19): 19185-19195.
[36]
Wu Q, Zhu M. Beta-catenin, cartilage and osteoarthritis[J]. Ann N Y Acad Sci, 2010, 3(1192): 344-350.
[37]
Zhu M, Chen M, Zuscik M, et al. Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction[J]. Arthritis Rheum, 2008, 58(7): 2053-2064.
Hardinqham TE, Oldershaw RA, Cartilage TS. SOX9 and notch signals in chondroqenesis[J]. J Anat, 2006, 209(4): 4460-4480.
[40]
Brew CJ, Clegg PD, Boot-Handford RP, et al. Gene expression in human chondrocytes in late osteoarthritis is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy[J]. Ann Rheum Dis, 2010, 69(1): 234-240.
[41]
Karlsson C, Brantsing C, Egell S, et al. Notch1, and HES5 are abundantly expressed in osteoarthritis[J]. Cells Tissues Organs, 2008, 188(3): 287-298.
[42]
Konttinen YT, Mandelin J, Li TF, et al. Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis[J]. Arthritis Rheum, 2002, 46(4): 953-960.
[43]
Berardi S, Lang A, Kostoulas G, et al. Alternative messenger RNA splicing and enzyme forms of cathepsin B in human osteoarthritic cartilage and cultured chondrocytes[J]. Arthritis Rheum, 2001, 44(8): 1819-1831.
